Icecure Historical Income Statement
| ICCM Stock | USD 0.83 0.04 5.34% |
Historical analysis of Icecure Medical income statement accounts such as Selling General Administrative of 2.4 M or Selling And Marketing Expenses of 4.7 M can show how well Icecure Medical performed in making a profits. Evaluating Icecure Medical income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Icecure Medical's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Icecure Medical latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Icecure Medical is a good buy for the upcoming year.
Icecure |
About Icecure Income Statement Analysis
Icecure Medical Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Icecure Medical shareholders. The income statement also shows Icecure investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Icecure Medical Income Statement Chart
Add Fundamental
Interest Expense
The cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit.Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Icecure Medical. It is also known as Icecure Medical overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Most accounts from Icecure Medical's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Icecure Medical current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Icecure Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. To learn how to invest in Icecure Stock, please use our How to Invest in Icecure Medical guide.At this time, Icecure Medical's Income Tax Expense is very stable compared to the past year. As of the 27th of November 2024, Net Interest Income is likely to grow to about 970.2 K, while Selling General Administrative is likely to drop about 2.4 M.
| 2021 | 2022 | 2023 | 2024 (projected) | Total Operating Expenses | 11.9M | 18.2M | 16.9M | 17.7M | Cost Of Revenue | 1.9M | 1.6M | 1.9M | 1.1M |
Icecure Medical income statement Correlations
Click cells to compare fundamentals
Icecure Medical Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Icecure Medical income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Depreciation And Amortization | (23.4K) | 63K | 127K | 248K | 323K | 339.2K | |
| Interest Expense | 22.8K | 31.7K | 171K | 239K | 215.1K | 120.2K | |
| Selling General Administrative | 1.3M | 1.8M | 4.1M | 5.9M | 4.2M | 2.4M | |
| Selling And Marketing Expenses | 1.0M | 1.1M | 1.9M | 3.2M | 4.4M | 4.7M | |
| Total Revenue | 1.7M | 4.1M | 4.1M | 3.1M | 3.2M | 2.1M | |
| Gross Profit | 576.4K | 2.7M | 2.2M | 1.4M | 1.3M | 957.4K | |
| Other Operating Expenses | 6.3M | 8.4M | 13.9M | 19.8M | 18.8M | 19.7M | |
| Operating Income | (4.6M) | (4.4M) | (9.7M) | (16.7M) | (15.6M) | (14.8M) | |
| Ebit | (4.6M) | (4.1M) | (9.7M) | (16.7M) | (15.6M) | (14.8M) | |
| Research Development | 2.8M | 4.1M | 5.9M | 9.1M | 8.3M | 8.7M | |
| Ebitda | (4.6M) | (4.1M) | (9.6M) | (16.5M) | (15.3M) | (14.5M) | |
| Cost Of Revenue | 1.1M | 1.4M | 1.9M | 1.6M | 1.9M | 1.1M | |
| Total Operating Expenses | 5.2M | 7.0M | 11.9M | 18.2M | 16.9M | 17.7M | |
| Income Before Tax | (4.8M) | (4.7M) | (9.9M) | (17.0M) | (14.7M) | (13.9M) | |
| Total Other Income Expense Net | (165.2K) | 412K | (171K) | (239K) | 924K | 970.2K | |
| Net Income | (4.8M) | (4.8M) | (10.1M) | (17.2M) | (14.7M) | (13.9M) | |
| Income Tax Expense | (13.6K) | 86.8K | 171K | 239K | 155.1K | 162.9K | |
| Net Interest Income | (698K) | (880K) | (171K) | (239K) | 924K | 970.2K | |
| Net Income From Continuing Ops | (16.5M) | (15.1M) | (9.9M) | (17.0M) | (14.7M) | (15.4M) | |
| Reconciled Depreciation | 538K | 856K | 127K | 248K | 323K | 365.2K | |
| Net Income Applicable To Common Shares | (16.5M) | (15.1M) | (9.9M) | (17.0M) | (15.3M) | (16.0M) |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Icecure Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. To learn how to invest in Icecure Stock, please use our How to Invest in Icecure Medical guide.You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Icecure Medical. If investors know Icecure will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Icecure Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.29) | Revenue Per Share 0.071 | Quarterly Revenue Growth 0.079 | Return On Assets (0.47) | Return On Equity (0.94) |
The market value of Icecure Medical is measured differently than its book value, which is the value of Icecure that is recorded on the company's balance sheet. Investors also form their own opinion of Icecure Medical's value that differs from its market value or its book value, called intrinsic value, which is Icecure Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Icecure Medical's market value can be influenced by many factors that don't directly affect Icecure Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Icecure Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Icecure Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Icecure Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.